Equities

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)1,946.10
  • Today's Change-1.80 / -0.09%
  • Shares traded149.33k
  • 1 Year change+31.05%
  • Beta--
Data delayed at least 15 minutes, as of Apr 19 2024 11:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Krishna Institute of Medical Sciences Ltd is an India-based company that is principally engaged in the business of rendering medical and healthcare services. The Company’s departments include accident, Alzheimer center, andrology and infertility center, pediatric obesity, pediatric oncology, pediatric oncology and hematology center, pediatric orthopedics and rheumatology, pediatric renal center, pediatric surgical center, female urology center, fertility center, gastrointestinal oncology, general surgery, heart wellness center and hepatobiliary surgery center. Its technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, EBUS, Spy Glass, Mako Robotic for Knee Replacement, and Impella. The Company’s institutes include the institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, and Institute of Neuro Sciences.

  • Revenue in INR (TTM)24.40bn
  • Net income in INR3.38bn
  • Incorporated1973
  • Employees10.00k
  • Location
    Krishna Institute of Medical Sciences Ltd1-8-31/1, Minister RoadSECUNDERABAD 500003IndiaIND
  • Phone+91 4 044885000
  • Fax+91 4 027840980
  • Websitehttps://www.kimshospitals.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Thyrocare Technologies Ltd5.54bn654.60m32.65bn1.65k50.42--29.805.9012.2312.23103.33--------3,364,803.00--19.87--22.5170.7570.0211.7121.55--29.63-----10.568.13-63.46-7.150.00--
Yatharth Hospital & Trauma Cre Srvcs Ltd-100.00bn-100.00bn38.57bn--------------------------------------------------29.77--48.92------
Healthcare Global Enterprises Ltd18.56bn352.59m51.53bn5.50k146.81--26.552.782.522.52132.66--------3,371,374.00---3.20---4.3553.2154.191.27-5.21--1.30----21.2715.28-45.387.42-12.26--
Vijaya Diagnostic Centre Ltd5.14bn1.13bn69.22bn2.00k61.45--41.7613.4811.0111.0150.08--------2,573,111.00--------87.90--22.14----6.57-----0.6727---22.84------
Jupiter Life Line Hospitals Ltd10.21bn1.47bn82.10bn3.14k50.98--43.428.0424.5624.56166.12------------------82.34--14.40----5.20----21.75--42.59------
Metropolis Healthcare Ltd11.59bn1.25bn89.13bn4.29k71.58--41.097.6924.3024.30225.81--------2,702,856.00--16.32--20.5279.0774.8810.8215.88--7.84--29.14-6.5212.15-33.296.5121.48--
Rainbow Children's Medicare Ltd12.73bn2.20bn131.97bn3.58k60.01--40.7810.3721.6721.67125.56--------3,554,214.00--------86.95--17.37----5.67----20.52--52.48------
Krishna Institute Of Medical Sciencs Ltd24.40bn3.38bn155.89bn10.00k46.12--31.256.3942.2442.24304.98--------2,440,276.00--12.90--16.4878.7754.1214.8813.59--14.05--0.0033.1327.061.09--57.91--
Dr. Lal PathLabs Ltd21.72bn3.30bn186.60bn4.05k56.64--39.048.5939.6339.63261.00--------5,366,063.00--16.20--20.0079.3675.5815.3516.01--13.68--26.75-3.3813.80-30.746.94-9.2721.67
Narayana Hrudayalaya Ltd49.64bn7.72bn251.54bn11.73k32.59--25.015.0738.0038.00244.45--------4,233,245.00--7.53--9.7461.3145.4015.556.62--10.06--10.8422.2514.6877.3063.84----
Aster DM Healthcare Ltd135.05bn3.24bn259.68bn24.65k80.10--20.111.926.516.51272.61--------5,478,007.00--3.41--5.1162.0161.382.934.08--2.25----16.3812.17-19.229.5810.29--
Data as of Apr 19 2024. Currency figures normalised to Krishna Institute of Medical Sciences Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

29.28%Per cent of shares held by top holders
HolderShares% Held
SBI Funds Management Ltd.as of 31 Mar 20245.76m7.20%
Axis Asset Management Co. Ltd.as of 31 Mar 20243.85m4.81%
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Mar 20243.40m4.26%
Nomura Asset Management Singapore Ltd.as of 29 Dec 20232.10m2.63%
The Vanguard Group, Inc.as of 05 Apr 20241.83m2.29%
Mirae Asset Investment Managers (India) Pvt Ltd.as of 23 Jan 20241.62m2.03%
HDFC Life Insurance Co. Ltd. (Investment Portfolio)as of 31 Mar 20241.40m1.75%
ICICI Prudential Asset Management Co. Ltd.as of 31 Mar 20241.35m1.68%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Mar 20241.06m1.33%
HSBC Asset Management (India) Pvt Ltd.as of 31 Mar 20241.05m1.31%
More ▼
Data from 31 Dec 2023 - 11 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.